UnitedHealth Group Valuation Shows Mixed Signals in DCF Analysis

UnitedHealth Group Inc (UNH) has seen a mixed price performance recently, with a slight decline of 1.2% over the past week and 6.4% over the past month, but it remains up by 14.9% year-to-date and 7.9% over the past year. The DCF analysis for UNH reveals a significant divergence in valuation perspectives. The earnings-based intrinsic value stands at $232.39, which is much lower than the current price of $371.90, indicating a -60.0% margin of safety and suggesting the stock is significantly overvalued. This model employs a two-stage approach, with a 10.2% growth rate for the first ten years and a 4% terminal growth rate, discounted at 12%.

In contrast, the free cash flow (FCF) DCF model yields an intrinsic value of $409.54, suggesting a fair value status with a 9.2% margin of safety. This discrepancy highlights the tension in valuation perspectives for UNH. The GF Value™, a proprietary measure from GuruFocus, stands at $591.67, adding another layer of analysis that suggests a more favorable outlook compared to the earnings-based model.

UnitedHealth Group Inc has a GF Score™ of 81/100, indicating strong fundamentals. However, its predictability rank is low at 0/5 stars, suggesting that the DCF model may be less reliable for this stock due to its unpredictable nature. The company's financial strength is rated 6/10, profitability 8/10, growth 6/10, valuation 4/10, and momentum 9/10. Investors should consider these insights carefully when evaluating their positions in UNH.

The guru ownership signal shows that 35 gurus currently hold the stock, with 14 adding to their positions while 21 are trimming. Additionally, insider activity indicates net selling over the past 12 months. These factors add further complexity to the valuation narrative for UNH.